Molecular, pharmacological and functional diversity of 5-HT receptors

Pharmacology Biochemistry and Behavior

Volumn 71, Issue 4, 2002, Pages 533-554

  Hoyer, Daniel ^a   Hannon, Jason P ^a   Martin, Graeme R ^a,b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b Discovery Insight   (United States)

Author keywords

5 HT; 5 Hydroxytryptamine; Receptor families and subtypes; Serotonin

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN RECEPTOR;

ARTICLE; GENE SWITCHING; GENETIC VARIABILITY; HUMAN; MOLECULAR BIOLOGY; MOLECULAR CLONING; MOLECULAR INTERACTION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; RNA EDITING; RNA SPLICING; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION;

EID: 0036119338     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00746-8     Document Type: Review

References (232)

1. Functional characterization of the recombinant human 5-hydroxytryptamine 7(a) receptor isoform coupled to adenylate cyclase stimulation
2. Electrophysiology of serotonin receptor subtypes and signal tranduction pathways
3. Serotonin and hallucinogens
4. How does pindolol improve antidepressant action?
5. 1B knockout
6. 7A receptor
7. 7) positively linked to adenylate cyclase
8. 4 receptors
9. 1E binding sites in rodent brains: Effect of lesion of serotonergic neurons
10. 3H]5-HT, in frontal cortex and the hippocampal region of the human brain
11. 1D receptor agonist
12. 4 splice variant
13. Serotonin and lysergic acid diethylamide binding in rat brain membranes: Relationship to postsynaptic serotonin receptors
14. 1B/1D receptor endogenous modulator, interacts with dopamine release measured in vivo by microdialysis
15. 1A receptors postsynaptic to serotoninergic neurons mediate spontaneous tail-flicks in the rat
16. 2C receptor modulation and the treatment of obesity
17. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia
18. 4 receptor cloned from human atrium
19. Cloning, expression and pharmacology of four human 5-hydroxy tryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus
20. 4 receptor: A place in the sun
21. Molecular biology of 5-HT receptors
22. Ultrastructure of the 5-hydroxytryptamine 3 receptor
23. Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide
24. 3H]RS-23597-190, a potent 5-hydroxytryptamine4 antagonist labels sigma-1 but not sigma-2 binding sites in guinea pig brain
25. 2C receptor antagonist
26. 2B receptor antagonist
27. Acute stress induces a differential increase of 5-HT-moduline (LSAL) tissue content in various rat brain areas
28. 6 receptor antagonists: Lead-optimization and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides
29. Drug mechanisms in anxiety
30. 6 receptor in the rat brain: A study using antisense oligonucleotides
31. Urinary disorders associated with cisapride
32. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine
33. 7 receptors
34. 6 receptors as emerging targets for drug discovery
35. 6 Receptor Antagonist
36. 6 antagonists: Identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134)
37. 1D recognition sites in the human substantia nigra identified with a new iodinated radioligand
38. 1F receptor mRNA in rodent and primate brain
39. 1C receptors
40. 4 receptor: Part 2. Structure activity studies of the indolecarbazimidamide agonist
41. 1D beta-like autoreceptors in the guinea-pig brain cortex
42. Regulation of serotonin-2C receptor G-protein coupling by RNA editing
43. Tegaserod
44. 5A serotonin receptor is expressed predominantly by astrocytes in which it inhibits cAMP accumulation: A mechanism for neuronal suppression of reactive astrocytes
45. Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea-pig isolated ileum
46. Identification and characterisation of a new serotonergic recognition site with high affinity for 5-carboxamidotryptamine in mammalian brain
47. 1B receptor
48. 4S receptors. Effect of receptor density on their coupling to adenylyl cyclase
49. 4 receptor splice variants show marked constitutive activity: Role of the C-terminal intracellular domain
50. 4 receptor ligands
51. 4 receptor: Naughty but nice
52. 3H]-5-hydroxytryptamine binding in the rat hypothalamus; identity with 5-hydroxytryptamine7 receptors
53. Characterisation of 5-Hydroxytryptamine receptors in rat stomach fundus
54. 1B receptors
55. Mapping of 5-HT-moduline binding sites in guinea-pig brain by film and digital autoradiography
56. 1B
57. Serotonin receptor-mediated activation of adenylate cyclase in the neuroblastoma NCB 20: A novel 5-hydroxytryptamine receptor
58. 2B receptor signaling in the rat stomach fundus: Dependence on calcium influx, calcium release and protein kinase C
59. 1B
60. Genetics of mouse behaviour: Interactions with laboratory environment
61. 1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis
62. 3B subunit is a major determinant of serotonin-receptor function
63. An analysis of the direct and indirect actions of drugs on the isolated guinea pig ileum
64. Eltoprazine in aggressive mentally handicapped patients: A double-blind, placebo- and baseline-controlled multi-centre study
65. Irritable bowel syndrome: New agents targeting serotonin receptor subtypes
66. Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist Ro 60-0175: A pharmacological analysis
67. Serotonergic drugs in the treatment of depressive and anxiety disorders
68. 1D/1B receptor antagonist
69. Systemic and regional Haemodynamic effects of the 5-hydroxytryptamine 1A receptor agonists flesinoxan and 8-hydroxy-2(di-N-propylamino)tetralin in the conscious rat
70. 3B receptor subunit
71. 3 serotonin receptor and uses thereof
72. Evidence for expression of the 5-hydroxytryptamine 2B receptor protein in the rat central nervous system
73. 2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat
74. 5-Hydroxytryptamine (5-HT)4 receptors and central nervous system function: An update
75. Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain
76. 7 receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neurons
77. 1A receptor
78. 5-Hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle
79. Potential of 5-HT-moduline as a drug target for affective disorders
80. 1B/1D receptors
81. The interactions of typical and atypical antipsychotics with the (-)2,5,-dimethoxy-4-methamphetamine (DOM) discriminative stimulus
82. 2C receptors in the stimulus effects of hallucinogenic drugs: II. Reassessment of LSD false positives
83. 2C receptor
84. 2B receptors in the cardiopathy associated with fenfluramine
85. 1A receptor antagonist
86. 2 receptors in the behaviors produced by intrathecal administration of selected 5-HT agonists and the TRH analog (CG 3509) to rats
87. 1A receptor antagonist, WAY 100635
88. o proteins and inhibits adenylate cyclase in HEK-293 cells
89. o proteins in Spodoptera frugiperda-9 cells
90. Two kinds of tryptamine receptor
91. 1B receptor inverse agonist 1′-methyl-5-[[2′-methyl-4′-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4′-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo
92. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties
93. 4 receptor: Molecular cloning and pharmacological characterization of two splice variants
94. Review article: Roles played by 5-hydroxytryptamine in the physiology of the bowel
95. 6 serotonin receptors
96. 5B receptor was lost during mammalian evolution
97. The effects of drugs on serotonin-mediated behavioral models
98. Immunocytochemical localization of neurons expressing 5-HT-moduline in the mouse brain
99. 5-Hydroxytryptamine-moduline: A novel endogenous peptide involved in the control of anxiety
100. 7 receptor in rat brain
101. 7 receptor antagonist
102. The role of serotonin and other neuroactive molecules in the physiopathogenesis of migraine: Current hypotheses
103. 3 receptors in rodents
104. 1D receptor genes
105. 1B receptor subtypes
106. Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine 7 receptors
107. 4 receptors
108. 7) receptor isoforms in human and rat produced by alternative splicing: Species differences due to altered intron-exon organization
109. 7) receptor isoforms produced by alternative splicing
110. 1A receptor mutant mice
111. 2C receptor RNA editing alters receptor basal activity: Implications for serotonergic signal transduction
112. 6 receptors in rat, pig and human brain tissue
113. 3 receptor A subunit
114. 1 autoreceptor subtypes govern serotonin release in dorsal and median raphe nuclei
115. 1D receptors in the human trigeminal ganglion: Co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase
116. 1C receptors
117. 4 and 5-HT-M receptors
118. 5-HT receptor classification and nomenclature: Towards a harmonization with the human genome
119. Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain
120. 125I]iodocyanopindolol
121. 3H]ketanserin
122. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
123. A new nomenclature for 5-HT receptors
124. 7b)
125. 2 receptor subtypes
126. 1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs
127. Adrenocorticotropic hormone secretion in rats induced by stimulation with serotonergic compounds
128. 1A receptor antagonists on the secretion of corticotropin and prolactin
129. 1A receptors
130. 4 receptors in human atrium: Facilitation by chronic β-adrenoceptor blockade
131. A receptor-activated current in cultured rat suprachiasmatic neurons
132. 2C/2B receptor antagonist
133. 2B receptor antagonist with anxiolytic-like properties
134. 2B receptor agonist, causes hyperphagia and reduced grooming in rats
135. 2C receptor antagonist
136. 6 serotonin receptor
137. Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus
138. 3 receptors
139. 1A receptor agonist 8-OH-DPAT
140. Oligomerization of dopamine and serotonin receptors
141. Orphan G protein-coupled receptors in the CNS
142. The inhibition by morphine of the action of smooth muscle stimulants on the guinea-pig intestine
143. 3H]alniditan
144. (7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl) pyrrolidine-1-sulfonyl) phenol (SB-269970)
145. 7) implicated in the regulation of mammalian circadian rhythms
146. 1 receptors and behavior
147. 3 receptor, a serotonin-gated ion channel
148. Receptors for 5-hydroxytryptamine: Current perspectives on classification and nomenclature
149. 2C receptor agonists: Pharmacological characteristics and therapeutic potential
150. Electrophysiological comparison of 5-hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing
151. 1B/1D receptors
152. Mouse 5-hydroxytryptamine 5A and 5-hydroxytryptamine 5B receptors define a new family of serotonin receptors: Cloning, functional expression, and chromosomal localization
153. Antidepressant-like behavioral effects in 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor mutant mice
154. Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine 1A agonist
155. Characterization of the serotonin receptor mediating contraction in the mouse thoracic aorta and signal pathway coupling
156. Increased mCPP-induced oral dyskinesia after lesion of serotonergic neurons
157. 6 receptor antagonist Ro 04-6790 on learning consolidation
158. 4e receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines
159. 4d receptor splice variant stably expressed in Chinese hamster ovary cells
160. 1B receptors
161. 1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor
162. 1B receptors
163. Induction of hypothermia as a model of 5-hydroxytryptamine 1A receptor-mediated activity in the rat A pharmacological characterization of the actions of novel agonists and antagonists
164. 2C receptors mediate penile erections in rats: Actions of novel and selective agonists and antagonists
165. Serotonin (5-HT) 2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo
166. 1E) serotonin receptors in human brain
167. 3 receptor splice variants in the rat
168. 7 receptor regulation in the rat hypothalamus
169. 35S]GTPγS binding study
170. Anaesthetic-like interaction of the sleep-inducing lipid oleamide with voltage-gated sodium channels in mammalian brain
171. RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity
172. 2C receptor alterations in suicide and implications for serotonergic pharmacotherapy
173. Tegaserod
174. Effects of 5-HT-moduline, a novel endogenous peptide, on serotonin release in the prefrontal cortex of freely moving rats
175. 6 receptor gene and schizophrenia
176. 3 receptor: Focus on alcohols and anaesthetic agents
177. Increased anxiety of mice lacking the serotonin 1A receptor
178. 1B/D receptor antagonists
179. 3H]-spiroperidol
180. 1F receptors: Binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine
181. 1D receptors in the rat brain
182. 1D receptors
183. Selective serotonin reuptake inhibitors and neuroendocrine function
184. 4 receptor antagonist RS-100302 in experimental atrial flutter and fibrillation
185. 1B receptor knock out - Behavioral consequences
186. 5-Hydroxytryptamine (5-HT) 4 receptors in post mortem human brain tissue: Distribution, pharmacology and effects of neurodegenerative diseases
187. 1b knockout mice
188. Interaction of serotonin autoreceptor antagonists in the rat dorsal raphe nucleus: An in vitro fast cyclic voltammetry study
189. 1B receptor selectivity for 5-HT terminal autoreceptor activity: An in vivo microdialysis study in the freely-moving guinea pig
190. 1B receptor inverse agonist, on in vivo extracellular 5-HT levels in the freely-moving guinea-pig
191. 7 receptor antagonist, on 5-HT release from serotonergic terminals and cell bodies
192. 1A receptor antagonist
193. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors
194. 2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications
195. 6 receptor antagonist
196. 7) activating cAMP formation
197. 1B receptor
198. Assignment of the 5-hydroxytryptamine (serotonin) receptor 5A gene (HTR5A) to human chromosome band 7q361
199. 1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors
200. 1A agonists
201. 6 receptors positively coupled to adenylyl cyclase in striatal neurons in culture
202. 1B receptor antagonist with negative intrinsic activity
203. Molecular cloning and expression of a 5-hydroxytryptamine 7 serotonin receptor subtype
204. 1B receptors activation is regulated by 5-HT-moduline
205. Serotonin and the structure of satiation
206. Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: Sensitivity to chronic antidepressant treatment
207. 6 receptors
208. Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide
209. 7 receptor (long form); antagonist profile of SB 258719
210. Oleamide-induced modulation of 5-hydroxytryptamine receptor-mediated signaling
211. 7 neurons in mouse thalamus and hypothalamus
212. (7) receptors
213. 7 receptors in guinea-pig brain
214. 5-Carboxamido-tryptamine: A potent agonist mediating relaxation and elevation of cyclic AMP in the isolated neonatal porcine vena cava
215. The behavioral response to 5-HT receptor agonists and subtypes of the central 5-HT receptor
216. Molecular basis of buspirone's anxiolytic action
217. Expression of serotonin receptor mRNAs in blood vessels
218. 2B receptor-mediated calcium release from ryanodine-sensitive intracellular stores in human pulmonary artery endothelial cells
219. 2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells
220. 4 receptor cDNA
221. 3 receptors and neurotransmitter release in the CNS: A nerve ending story?
222. 2C receptors
223. Psilosybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
224. 1F receptor binding sites in the guinea pig brain: An autoradiographic study
225. 1D receptor antagonist in native tissue
226. Assignment of a human homolog of the mouse Htr3 receptor gene to chromosome 11q23.1-q23.2
227. Serotonin and animal behavior
228. 4 receptors in brain tissues from patients with neurodegenerative disorders
229. 6 receptors in retention of spatial learning in the Morris water maze
230. 1D receptors form homodimers when expressed alone and heterodimers when co-expressed
231. 7 receptor mRNA expression in the rat hippocampus
232. 1B receptors